Research output per year
Research output per year
Personal profile
Education/Academic qualification
Msc. Pharm.
Fields of Science
- 3121 General medicine, internal medicine and other clinical medicine
- Clinical Pharmacology
International and National Collaboration
Publications and projects within past five years.
-
Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4 and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A in vitro
Paludetto, M-N. I. A., Kurkela, M., Kahma, H., Backman, J. T., Niemi, M. & Filppula, A. M., 1 Mar 2023, In: Drug Metabolism and Disposition. 51, 3, p. 293-305 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Hydroxychloroquine is metabolized by CYP2D6, CYP3A4 and CYP2C8, and inhibits CYP2D6, while its metabolites also inhibit CYP3A4 in vitro
Paludetto, M-N. I. A., Kurkela, M., Kahma, H., Backman, J., Niemi, M. & Filppula, A. M., 7 Jun 2022.Research output: Conference materials › Abstract
-
Hydroxychloroquine is metabolized by CYP2D6, CYP3A4 and CYP2C8, and inhibits CYP2D6 in vitro
Paludetto, M-N. I. A., Kurkela, M., Kahma, H., Backman, J., Niemi, M. & Filppula, A. M., 2022, (Unpublished).Research output: Conference materials › Poster
-
In Vitro Inhibitory Effects andMechanisms of Tyrosine Kinase Inhibitors on Warfarin Metabolism
Jin, S., Paludetto, M-N. I. A., Kurkela, M., Kahma, H., Neuvonen, M., Cai, W. & Backman, J., 7 Jun 2022.Research output: Conference materials › Abstract
-
In Vitro Inhibitory Effects and Mechanisms of Tyrosine Kinase Inhibitors on Warfarin Metabolism
Jin, S., Paludetto, M-N. I. A., Kurkela, M., Kahma, H., Neuvonen, M., Cai, W. & Backman, J., 2022, (Unpublished).Research output: Conference materials › Poster
-
JUSELIUS 22-25 BACKMAN JANNE
Backman, J., Kahma, H. & Paludetto, M. I. A.
01/05/2022 → 31/12/2024
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Academy of Finland Project Funding: Mechanism-Based Inactivation of Cytochrome P450 (Palautumaton sytokromi P450-entsyymien esto ja kliinisesti merkittävät lääkeaineyhteisvaikutukset: Yhteisvaikutuksia in vitro tiedosta ennustavien menetelmien kehittäminen)
Backman, J., Niemi, M., Tornio, A., Filppula, A. M., Neuvonen, P., Neuvonen, M., Launiainen, T., Kahma, H., Kaartinen, T. & Itkonen, M.
01/09/2014 → 31/08/2018
Project: Research project
Prizes
-
-
Best three minute thesis presentation, FPDP-C section
Kahma, Helinä (Recipient), 20 Aug 2015
Prize: Prizes and awards
Activities
-
The 50th Gordon Research Conference on Drug Metabolism
Helinä Kahma (Poster Presentation)
10 Jul 2022 → 15 Jul 2022Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
-
Pharmacogenetics at the University of Helsinki
Helinä Kahma (Speaker: Presenter)
28 May 2019 → 29 May 2019Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
-
Joint 25th Anniversary Symposium of Teratology Information Service and Finnish Society of Clinical Pharmacology
Helinä Kahma (Poster Presentation)
4 Dec 2019Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
-
12th International ISSX meeting
Helinä Kahma (Poster Presentation)
28 Jul 2019 → 31 Jul 2019Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
-
Improving Rational Pharmacotherapy - 50 years of Clinical Pharmacology in Finland
Helinä Kahma (Member of organizing committee)
8 Nov 2018 → 9 Nov 2018Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars